You have 9 free searches left this month | for more free features.

Tumour neoantigens

Showing 1 - 25 of 1,787

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Colorectal Cancer Trial in Stockholm, Västerås (pTTL)

Recruiting
  • Colorectal Cancer
  • Stockholm, Sweden
  • +1 more
Jun 7, 2023

Hepatocellular Carcinoma, Hepatocellular Cancer, Colorectal Cancer Trial in Singapore (Neoantigen Dendritic Cell Vaccine,

Recruiting
  • Hepatocellular Carcinoma
  • +4 more
  • Singapore, Singapore
    National Cancer Center Singapore
Aug 17, 2022

Unresectable Melanoma, Metastatic Melanoma Trial in Brussel, Amsterdam, Barcelona (NEO-PTC-01)

Recruiting
  • Unresectable Melanoma
  • Metastatic Melanoma
  • NEO-PTC-01
  • Brussel, Belgium
  • +2 more
Dec 5, 2022

Advanced Head and Neck Squamous Cell Carcinoma, Advanced Breast Cancer, Advanced Melanoma Trial in Worldwide (CyPep-1,

Not yet recruiting
  • Advanced Head and Neck Squamous Cell Carcinoma
  • +2 more
  • CyPep-1
  • Pembrolizumab 25 MG/ML [Keytruda]
  • Pittsburgh, Pennsylvania
  • +18 more
Nov 21, 2022

Treatment in Cancers of Head and Neck

Recruiting
  • Head and Neck Cancer
  • Circulating tumour DNA dynamics
  • London, United Kingdom
    The Royal Marsden Hospital
Dec 6, 2022

Metastatic Colorectal Cancer, pMMR, MSS Trial in France (Atezolizumab, Therasphere, XELOX)

Recruiting
  • Metastatic Colorectal Cancer
  • +4 more
  • Amiens, France
  • +18 more
Mar 23, 2022

Gastric Cancer Associated Neoantigens

Not yet recruiting
  • Gastric Cancer
  • Neoantigens
  • ratio of predicted neoantigens
  • Ho Chi Minh City, Vietnam
    University Medical Center Ho Chi Minh City
Aug 9, 2022

Esophageal Cancer Associated Neoantigens

Not yet recruiting
  • Esophageal Cancer
  • Neoantigen
  • ratio of predicted neoantigens
  • Ho Chi Minh City, Vietnam
    University Medical Center Ho Chi Minh City
Aug 9, 2022

Lynch Syndrome Trial in Puerto Rico, United States (Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP, MVA

Recruiting
  • Lynch Syndrome
  • Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP
  • +2 more
  • Duarte, California
  • +3 more
Nov 22, 2022

NSCLC Trial in Ghent (Dendritic cell immunotherapy, Antigen-specific DTH, Control DTH)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Dendritic cell immunotherapy
  • +2 more
  • Ghent, Belgium
    Ghent University Hospital
Dec 23, 2022

Gynecologic Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Houston (Neoantigen specific TCR-T cell drug product,

Recruiting
  • Gynecologic Cancer
  • +11 more
  • Neoantigen specific TCR-T cell drug product
  • Aldesleukin (IL-2)
  • Houston, Texas
    MD Anderson Cancer Center
Jul 27, 2022

Melanoma Trial in Lausanne (Tc-99m tilmanocept)

Recruiting
  • Melanoma
  • Tc-99m tilmanocept
  • Lausanne, Vaud, Switzerland
    Centre Hospitalier Universitaire Vaudois
Jun 11, 2022

Anal Cancer Trial in Gothenburg (Biopsies)

Not yet recruiting
  • Anal Cancer
  • Biopsies
  • Gothenburg, Sweden
    Dept. of Surgery, Sahlgrenska University Hospital/Ostra
Jul 3, 2023

Metastatic Colorectal Cancer Trial in Spain (Olaparib, Pembrolizumab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Sevilla, Andalucia, Spain
  • +14 more
Aug 2, 2022

Advanced Solid Tumor Trial in Shanghai (Personalized neoantigen tumor vaccine)

Recruiting
  • Advanced Solid Tumor
  • Personalized neoantigen tumor vaccine
  • Shanghai, Shanghai, China
    Ruijin Hospital Shanghai Jiaotong University School of Medicine
Jun 24, 2023

Advanced Pancreatic Cancer Trial in Qionghai (Personalized neoantigen tumor vaccine)

Recruiting
  • Advanced Pancreatic Cancer
  • Personalized neoantigen tumor vaccine
  • Qionghai, Hainan, China
    Ruijin-Hainan Hospital Affiliated to Shanghai Jiao Tong Universi
Jun 14, 2023

Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer Trial in United States (GRT-C903, GRT-R904, nivolumab)

Recruiting
  • Non-Small Cell Lung Cancer
  • +4 more
  • GRT-C903
  • +3 more
  • Phoenix, Arizona
  • +13 more
Jan 30, 2023

Glioblastoma Multiforme, Adult, Recurrent Glioblastoma Trial in Rotterdam (Pitavastatin calcium)

Not yet recruiting
  • Glioblastoma Multiforme, Adult
  • Recurrent Glioblastoma
  • Pitavastatin calcium
  • Rotterdam, Netherlands
    Erasmus MC
Aug 3, 2023

Glioma, Malignant, Antigen-specific Vaccines, Individualized Treatment Trial in Shanghai (NeoPep Vaccine1 plus Poly-ICLC, NeoPep

Recruiting
  • Glioma, Malignant
  • +2 more
  • NeoPep Vaccine1 plus Poly-ICLC
  • NeoPep Vaccine2 plus Poly-ICLC
  • Shanghai, Shanghai, China
    Shanghai 10th People's Hospital
Oct 7, 2022

less Image Guidance Using Intrafraction Kolovoltage X-ray

Recruiting
  • Lung Cancer
  • +2 more
  • Markerless Tumour Tracking
  • Saint Leonards, New South Wales, Australia
    Royal North Shore Hospital
Oct 25, 2022

Breast Cancer, Breast Cancer Invasive Trial in Groningen (Fluorescence guided detection of tumor positive margins.)

Not yet recruiting
  • Breast Cancer
  • Breast Cancer Invasive
  • Fluorescence guided detection of tumor positive margins.
  • Groningen, Netherlands
  • +1 more
Jul 10, 2023

Prospective Tissue Collection Research Protocol

Recruiting
  • Solid Tumor
  • Tumour tissue collection
  • New York, New York
  • +17 more
Jan 16, 2023

Glioblastoma Trial in Rotterdam (Extended MRI)

Recruiting
  • Glioblastoma
  • Extended MRI
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus Medical Center
Jul 24, 2023

Clear Cell Renal Cell Carcinoma Metastatic, TNBC - Triple-Negative Breast Cancer, Head Neck Cancer Trial (CA9hu-1)

Not yet recruiting
  • Clear Cell Renal Cell Carcinoma Metastatic
  • +4 more
  • (no location specified)
Jan 13, 2023

Lung Cancer, Primary Tumor, Metastases Trial in Tønsberg (Genome analysis of tissue samples.)

Active, not recruiting
  • Lung Cancer
  • +2 more
  • Genome analysis of tissue samples.
  • Tønsberg, Norway
    Vestfold Hospital Trust
Jan 19, 2023